DigiDiab Pilot: Impact Study Hospital

Recruiting now

Conditions studied: Type 2 Diabetes

In brief

GlucoTab is an innovative workflow and decision support tool for standardised diabetes management by healthcare professionals which provides automated and personalised dosage recommendations for different insulin therapy regimens.

Key facts

Study ID: NCT06605872
Run by: Medical University of Graz
People needed: 500
Starts: 2025-04-01
Expected to finish: 2025-10-31
Last updated by the study team: 2025-08-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

informed consent obtained after being advised of the nature of the study
a documented history of type 2 diabetes prior to inclusion or new-onset hyperglycaemia which requires s.c. insulin therapy during hospital stay
admission to either surgical or internal medicine ward
an expected length of hospital stay for at least 48 hours after enrolment

You may not qualify if…

type 1 diabetes mellitus
intravenous insulin therapy
hyperglycaemic episodes (ketoacidosis, hyperosmolar state) if they require intravenous insulin therapy
continuous subcutaneous insulin infusion
gestational diabetes or pregnancy
known or suspected allergy to insulin
total parenteral nutrition
any mental condition rendering the patient incapable of giving his/her consent
any disease or condition which according to the investigator or treating physician would interfere with the trial or the safety of the patient
Inclusion and exclusion criteria will be the same as above for the retrospective CG with the exception of:
period of time will be from September 2022 to September 2023
no informed consent will be obtained from the retrospective CG

Where it is running

Hospital Universitari Joan XXIII de Tarragona — Tarragona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.